
DBD Stock Forecast & Price Target
DBD Analyst Ratings
Bulls say
Diebold Nixdorf Inc. has demonstrated robust growth, with a notable 20% year-over-year increase in product revenues within the Banking segment, which constitutes a significant portion of its revenue. The company's order entry for 2025 has risen approximately 17% year-over-year, reflecting strong demand across both the banking and retail sectors and indicating momentum that extends into early 2026. Additionally, the transition to consistently positive free cash flow, evidenced by a 5.4% year-over-year increase in fourth-quarter free cash flow to $196 million, positions the company favorably for sustained financial improvement going forward.
Bears say
Diebold Nixdorf Inc. faces a negative outlook due to a projected decline in backlog, anticipated seasonal revenue decreases in CQ1, and ongoing risks related to tariff costs and supply chain disruptions. The company's recent financial results showed modestly missed revenue targets while experiencing a decline in backlog from $980M to $920M, raising concerns about order volatility and upgrade activity within its Banking segment. Additionally, challenges such as foreign exchange volatility, liquidity issues, and inefficiencies in product shipments exacerbate the uncertainty surrounding future cash flow generation and financial stability.
This aggregate rating is based on analysts' research of Diebold Nixdorf Inc and is not a guaranteed prediction by Public.com or investment advice.
DBD Analyst Forecast & Price Prediction
Start investing in DBD
Order type
Buy in
Order amount
Est. shares
0 shares